Vikram Mathews

7.3k total citations
293 papers, 4.0k citations indexed

About

Vikram Mathews is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Vikram Mathews has authored 293 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 201 papers in Hematology, 81 papers in Molecular Biology and 79 papers in Genetics. Recurrent topics in Vikram Mathews's work include Acute Myeloid Leukemia Research (82 papers), Hematopoietic Stem Cell Transplantation (81 papers) and Acute Lymphoblastic Leukemia research (46 papers). Vikram Mathews is often cited by papers focused on Acute Myeloid Leukemia Research (82 papers), Hematopoietic Stem Cell Transplantation (81 papers) and Acute Lymphoblastic Leukemia research (46 papers). Vikram Mathews collaborates with scholars based in India, United States and France. Vikram Mathews's co-authors include Biju George, Alok Srivastava, Mammen Chandy, Auro Viswabandya, Poonkuzhali Balasubramanian, Shaji R Velayudhan, Kavitha M. Lakshmi, Aby Abraham, Anu Korula and Vivi M. Srivastava and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Vikram Mathews

264 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vikram Mathews India 36 2.6k 1.6k 877 702 678 293 4.0k
Pau Montesinos Spain 35 3.8k 1.5× 2.8k 1.7× 789 0.9× 996 1.4× 1.1k 1.6× 309 5.3k
Mammen Chandy India 32 2.0k 0.8× 1.0k 0.6× 673 0.8× 532 0.8× 377 0.6× 156 2.9k
David Bowen United Kingdom 36 4.4k 1.7× 2.1k 1.3× 1.7k 2.0× 862 1.2× 500 0.7× 132 5.4k
Pierre W. Wijermans Netherlands 24 2.4k 0.9× 1.7k 1.1× 576 0.7× 604 0.9× 886 1.3× 69 3.7k
Jaroslav Čermák Czechia 25 2.1k 0.8× 1.5k 0.9× 788 0.9× 398 0.6× 372 0.5× 192 3.7k
R Ohno Japan 33 4.1k 1.6× 2.2k 1.4× 1.1k 1.3× 1.3k 1.8× 1.2k 1.7× 104 5.7k
Amy E. DeZern United States 34 2.4k 0.9× 948 0.6× 985 1.1× 417 0.6× 513 0.8× 202 3.7k
Martha Arellano United States 27 2.6k 1.0× 2.0k 1.2× 720 0.8× 870 1.2× 848 1.3× 119 4.4k
Sally Killick United Kingdom 28 2.3k 0.9× 749 0.5× 894 1.0× 271 0.4× 422 0.6× 68 3.2k
John E. Godwin United States 28 2.6k 1.0× 1.6k 1.0× 764 0.9× 922 1.3× 1.3k 1.9× 110 4.1k

Countries citing papers authored by Vikram Mathews

Since Specialization
Citations

This map shows the geographic impact of Vikram Mathews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikram Mathews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikram Mathews more than expected).

Fields of papers citing papers by Vikram Mathews

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikram Mathews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikram Mathews. The network helps show where Vikram Mathews may publish in the future.

Co-authorship network of co-authors of Vikram Mathews

This figure shows the co-authorship network connecting the top 25 collaborators of Vikram Mathews. A scholar is included among the top collaborators of Vikram Mathews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikram Mathews. Vikram Mathews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Balakrishnan, Balaji, et al.. (2024). Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia. Annals of Hematology. 103(6). 1919–1929. 2 indexed citations
2.
Doxzen, Kevin, Jennifer E. Adair, Yris Maria Fonseca-Bazzo, et al.. (2024). The translational gap for gene therapies in low- and middle-income countries. Science Translational Medicine. 16(746). eadn1902–eadn1902. 20 indexed citations
3.
4.
Panetta, John C., Uday Kulkarni, Balaji Balakrishnan, et al.. (2023). Treosulfan Exposure Predicts Thalassemia‐Free Survival in Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Cell Transplantation. Clinical Pharmacology & Therapeutics. 115(1). 116–125. 2 indexed citations
5.
Devasia, Anup J., et al.. (2023). Patterns of Renal Dysfunction and Profile of Kidney Biopsies in Hematopoietic Stem Cell Transplant Recipients. SHILAP Revista de lepidopterología. 3(1). 98–115. 2 indexed citations
6.
Sousos, Nikolaos, Máire Ní Leathlobhair, Christina Simoglou Karali, et al.. (2022). In utero origin of myelofibrosis presenting in adult monozygotic twins. Nature Medicine. 28(6). 1207–1211. 33 indexed citations
7.
8.
Balasubramanian, P., Susanne Pulimood, Kavitha M. Lakshmi, et al.. (2021). Limited utility of plasma elafin as a biomarker for skin graft‐versus‐host disease following allogeneic stem cell transplantation. Clinical and Experimental Dermatology. 46(8). 1482–1487. 5 indexed citations
9.
Balasundaram, Nithya, Saravanan Ganesan, Ezhilarasi Chendamarai, et al.. (2021). Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia. Blood Advances. 6(2). 652–663. 10 indexed citations
10.
Ganesan, Saravanan, Nithya Balasundaram, Sachin David, et al.. (2020). Combination Lenalidomide/Bortezomib Treatment Synergistically Induces Calpain-Dependent Ikaros Cleavage and Apoptosis in Myeloma Cells. Molecular Cancer Research. 18(4). 529–536. 11 indexed citations
11.
Balakrishnan, Balaji, Kavitha M. Lakshmi, Thenmozhi Mani, et al.. (2020). Prognostic plasma biomarkers of early complications and graft‐versus‐host disease in patients undergoing allogeneic hematopoietic stem cell transplantation. SHILAP Revista de lepidopterología. 1(1). 219–229. 12 indexed citations
12.
Kulkarni, Uday, Saravanan Ganesan, Ansu Abu Alex, et al.. (2020). A phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide. Cancer Medicine. 9(8). 2603–2610. 21 indexed citations
13.
Li, Chunfu, Vikram Mathews, Soyoung Kim, et al.. (2019). Related and unrelated donor transplantation for β-thalassemia major: results of an international survey. Blood Advances. 3(17). 2562–2570. 48 indexed citations
14.
Arunachalam, Arun Kumar, Eunice Sindhuvi Edison, Anu Korula, et al.. (2018). Spectrum of ELANE mutations in congenital neutropenia: a single-centre study in patients of Indian origin. Journal of Clinical Pathology. 71(12). 1046–1050. 9 indexed citations
15.
Korula, Anu, M. Kavitha, Marie Therese Manipadam, et al.. (2018). Peripheral T cell lymphoma. The Indian Journal of Medical Research. 147(5). 464–470. 7 indexed citations
16.
17.
Ganesan, Saravanan, Vairavan Lakshmanan, Nithya Balasundaram, et al.. (2017). Stromal-Cells Downregulate MiR-23a-5p Levels in Myeloid Leukemic Cells to Activate Protective-Autophagy Against Chemotherapeutic Agents. Blood. 130. 3780–3780. 1 indexed citations
18.
Abraham, Aby, Shashikant Apte, Anu Korula, et al.. (2017). Meaningful Reduction of Annual Bleeding Rate with Lower Dose Prophylaxis in Minimally Treated Children with Hemophilia in India. Blood. 130. 1079–1079. 3 indexed citations
19.
David, Sachin, Uday Kulkarni, Anu Korula, et al.. (2015). Coagulopathy in Acute Promyelocytic Leukemia: Strategies to Improve Assessment of Hemostatic Risk. Blood. 126(23). 3758–3758. 1 indexed citations
20.
George, Biju, Ezhilarasi Chendamarai, Kavitha M. Lakshmi, et al.. (2009). Comparison of Clinical Outcomes of Patients with Relapsed Acute Promyelocytic Leukemia Induced with Arsenic Trioxide and Consolidated with Either an Autologous Stem Cell Transplant or an Arsenic Trioxide–Based Regimen. Biology of Blood and Marrow Transplantation. 15(11). 1479–1484. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pau Montesinos Breakdown of academic impact, for papers by Mammen Chandy Breakdown of academic impact, for papers by David Bowen Breakdown of academic impact, for papers by Pierre W. Wijermans Breakdown of academic impact, for papers by Jaroslav Čermák Breakdown of academic impact, for papers by R Ohno Breakdown of academic impact, for papers by Amy E. DeZern Breakdown of academic impact, for papers by Martha Arellano Breakdown of academic impact, for papers by Sally Killick Breakdown of academic impact, for papers by John E. Godwin
Rankless by CCL
2026